# Celaxia Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/celaxia-co

- Industry: Biotechnology
- Headquarters: Tokyo, Japan
- Website: www.cellaxia.co.jp
- Total disclosed funding: $12M
- Latest round: Series C (Jun 14, 2024)
- Investors on record: 12

## About

Based in Tokyo, Japan, and founded in 2017 by CEO Makoto Seki, CellAxia Inc. operates as a biopharmaceutical company specializing in regenerative medicine. The company engages in the research, development, manufacturing, and sale of pharmaceuticals. In June 2024, CellAxia Inc. raised venture funding from Venture Labo Investment.  

CellAxia Inc. specializes in research and development for the pharmaceuticals industry. The firm manufactures and sales pharmaceuticals and regenerative medicine products.

## Funding rounds

- Series C, Jun 14, 2024, $0.6M — Venture Labo Investment
- Series C, Aug 19, 2022, $4.7M — Mitsubishi UFJ Capital, Mizuho Capital, Miyako Capital, Oita Venture Capital, Kyoto Capital Partners, AJ Capital, SBI Okasan Alternative Investment, SRD Holdings, GREEN CORE
- Series B, Sep 10, 2020, $7.1M — Mitsubishi UFJ Capital, Mizuho Capital, M3, Inc., Miyako Capital, FFG Venture Business Partners, SBI Okasan Alternative Investment

## Investors

- Mitsubishi UFJ Capital (https://capitalatlas.ai/funds/mitsubishi-ufj-capital) — Series B, Series C
- Mizuho Capital (https://capitalatlas.ai/funds/mizuho-capital) — Series B, Series C
- M3, Inc. — Series B
- Miyako Capital (https://capitalatlas.ai/funds/miyako-capital) — Series B, Series C
- FFG Venture Business Partners (https://capitalatlas.ai/funds/ffg-venture-business-partners) — Series B
- SBI Okasan Alternative Investment (https://capitalatlas.ai/funds/sbi-okasan-alternative-investment) — Series B, Series C
- Oita Venture Capital (https://capitalatlas.ai/funds/oita-venture-capital) — Series C
- Kyoto Capital Partners (https://capitalatlas.ai/funds/kyoto-capital-partners) — Series C
- AJ Capital — Series C
- SRD Holdings — Series C
- GREEN CORE — Series C
- Venture Labo Investment (https://capitalatlas.ai/funds/venture-labo-investment) — Series C